Accolade price target raised to $14 from $12 at Truist

Truist analyst Jailendra Singh raised the firm’s price target on Accolade (ACCD) to $14 from $12 and keeps a Buy rating on the shares. Following the company’s Comcast (CMCSA) contract loss last year, investors got skeptical about the stickiness of employee advocacy and engagement offerings, but the firm’s benefit guide review underscores the view that Comcast was a "one-off" situation and these contracts remain highly sticky, the analyst tells investors in a research note. Accolade’s 2nd.MD business is also benefiting not only from some new contract wins but also from employers pushing to drive more utilization, the firm adds.